| Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease Z Chen, R Tian, Z She, J Cai, H Li Free Radical Biology and Medicine 152, 116-141, 2020 | 912 | 2020 |
| An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury XJ Zhang, XU Cheng, ZZ Yan, J Fang, X Wang, W Wang, ZY Liu, LJ Shen, ... Nature medicine 24 (1), 73-83, 2018 | 221 | 2018 |
| Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species XJ Zhang, X Liu, M Hu, GJ Zhao, D Sun, X Cheng, H Xiang, YP Huang, ... Cell metabolism 33 (10), 2059-2075. e10, 2021 | 55 | 2021 |
| Integrated omics reveals tollip as an regulator and therapeutic target for hepatic ischemia‐reperfusion injury in mice ZZ Yan, YP Huang, X Wang, HP Wang, F Ren, RF Tian, X Cheng, J Cai, ... Hepatology 70 (5), 1750-1769, 2019 | 54 | 2019 |
| A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques XJ Zhang, YX Ji, X Cheng, Y Cheng, H Yang, J Wang, LP Zhao, ... Science translational medicine 13 (624), eabg8116, 2021 | 39 | 2021 |
| Milk fat globule–epidermal growth factor–Factor 8 improves hepatic steatosis and inflammation L Zhang, R Tian, X Yao, XJ Zhang, P Zhang, Y Huang, ZG She, H Li, YX Ji, ... Hepatology 73 (2), 586-605, 2021 | 36 | 2021 |
| Corrigendum to" Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease"[Free Radic. Biol. Med. 152 (2020) 116-141] Z Chen, R Tian, Z She, J Cai, H Li Free radical biology & medicine 162, 174, 2021 | 8 | 2021 |
| Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction Z Yang, R Tian, XJ Zhang, J Cai, ZG She, H Li Frontiers in Cardiovascular Medicine 9, 1120085, 2023 | 6 | 2023 |
| A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure Z Wang, W Shi, T Wu, T Peng, X Wang, S Liu, Z Yang, J Wang, PL Li, ... Frontiers in Cardiovascular Medicine 10, 1130635, 2023 | 4 | 2023 |
| Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome R Tian, J Yang, X Wang, S Liu, R Dong, Z Wang, Z Yang, Y Zhang, Z Cai, ... Chinese Medicine 18 (1), 30, 2023 | 3 | 2023 |
| Network-based analysis identifies key regulatory transcription factors involved in skin aging XM Wang, K Ming, S Wang, J Wang, PL Li, RF Tian, SY Liu, X Cheng, ... Experimental Gerontology 178, 112202, 2023 | 2 | 2023 |
| Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progression L Bai, W Qu, X Cheng, H Yang, YP Huang, Z Wang, C Han, RF Tian, F Hu, ... Science Translational Medicine 16 (734), eade7347, 2024 | | 2024 |